deltatrials
Terminated PHASE4 NCT00486343

Zileuton CR vs Placebo in Poorly Controlled Asthma Patients on Moderate Dose ICS

A Randomized, Double-Blind, Placebo Controlled Study of Zileuton CR Tablets Versus Placebo in Adult Patients With Poorly Controlled Asthma Patients on Moderate Dose Inhaled Corticosteroids (ICS)

Sponsor: Critical Therapeutics

Conditions Asthma
Interventions Placebo Zileuton CR
Updated 6 times since 2017 Last updated: Apr 1, 2008 Started: Jul 31, 2007 Primary completion: May 31, 2008 Completion: Jun 30, 2008

A PHASE4 clinical study on Asthma, this trial is terminated or withdrawn. The trial is conducted by Critical Therapeutics and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Terminated PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Terminated PHASE4

  5. Feb 2017 — Jun 2018 [monthly]

    Terminated PHASE4

▶ Show 1 earlier version

  1. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE4

    First recorded

Jul 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Critical Therapeutics
Data source: Critical Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Lexington, United States